SGLT2 Inhibitors as Modulators of Mitochondrial Ion Transport and ER-Mitochondria Crosstalk in Diabetic Cardiomyopathy

Scritto il 29/07/2026
da Jessa Flores

Am J Physiol Cell Physiol. 2026 Jul 29. doi: 10.1152/ajpcell.00230.2026. Online ahead of print.

ABSTRACT

Diabetic cardiomyopathy (DCM) is a major complication of type 2 diabetes mellitus and a leading contributor to heart failure. A central feature of DCM is the disruption of mitochondrial bioenergetics and calcium homeostasis, processes that are tightly regulated through mitochondria-associated endoplasmic reticulum membranes (MAMs). These ER-mitochondria contact sites coordinate mitochondrial ion transport systems, including the mitochondrial calcium uniporter (MCU), Na⁺/Ca²⁺ exchanger (NCLX), and potassium channels, which collectively govern mitochondrial metabolism, redox balance, and cell survival.

PMID:42526021 | DOI:10.1152/ajpcell.00230.2026